Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - Eledon Pharmaceuticals, Inc. | nvus-ex322_8.htm |
| EX-32.1 - EX-32.1 - Eledon Pharmaceuticals, Inc. | nvus-ex321_12.htm |
| EX-31.2 - EX-31.2 - Eledon Pharmaceuticals, Inc. | nvus-ex312_6.htm |
| EX-31.1 - EX-31.1 - Eledon Pharmaceuticals, Inc. | nvus-ex311_11.htm |
| EX-10.11 - EX-10.11 - Eledon Pharmaceuticals, Inc. | nvus-ex1011_319.htm |
| EX-10.10 - EX-10.10 - Eledon Pharmaceuticals, Inc. | nvus-ex1010_316.htm |
| EX-10.9 - EX-10.9 - Eledon Pharmaceuticals, Inc. | nvus-ex109_317.htm |
| EX-10.8 - EX-10.8 - Eledon Pharmaceuticals, Inc. | nvus-ex108_318.htm |
| EX-4.5 - EX-4.5 - Eledon Pharmaceuticals, Inc. | nvus-ex45_320.htm |
| EX-1.1 - EX-1.1 - Eledon Pharmaceuticals, Inc. | nvus-ex11_777.htm |
| 10-K - 10-K - Eledon Pharmaceuticals, Inc. | nvus-10k_20201231.htm |
|
|
|
Exhibit 23.1 |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in Registration Statement Nos. 333-200413, 333-203032, 333-210058, 333-216432, 333-232428 and 333-237380 on Form S-8 and Registration Statement Nos. 333-226286 and 333-251305 on Form S-3 of our report dated March 30, 2021, relating to the consolidated financial statements of Eledon Pharmaceuticals, Inc., appearing in this Annual Report on Form 10-K of Eledon Pharmaceuticals, Inc. for the year ended December 31, 2020.
/s/ KMJ Corbin & Company LLP
Irvine, California
March 30, 2021
|
|
|
|